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Resistance to human skin innate defenses is
crucial for survival and carriage of Staphylococ-
cus aureus, a common cutaneous pathogen
and nasal colonizer. Free fatty acids extracted
from human skin sebum possess potent antimi-
crobial activity against S. aureus. The mecha-
nisms by which S. aureus overcomes this host
defense during colonization remain unknown.
Here, we show that S. aureus IsdA, a surface
protein produced in response to the host, de-
creases bacterial cellular hydrophobicity ren-
dering them resistant to bactericidal human
skin fatty acids and peptides. IsdA is required
for survival of S. aureus on live human skin. Re-
ciprocally, skin fatty acids prevent the produc-
tion of virulence determinants and the induction
of antibiotic resistance in S. aureus and other
Gram-positive pathogens. A purified human
skin fatty acid was effective in treating systemic
and topical infections of S. aureus suggesting
that our natural defense mechanisms can be
exploited to combat drug-resistant pathogens.
INTRODUCTION
Staphylococcus aureus is a highly adaptable human path-
ogen responsible for many infections and fatalities world-
wide; the spread of antibiotic resistance is alarming as it
limits available therapies (Waldvogel, 1995). As a common
cutaneous and nasal commensal and pathogen, resis-
tance to human skin innate defenses is a crucial require-
ment for survival and colonization. Human skin gives
physical protection partly because it is composed of
tightly associated epithelial cells covered by a highly
cross-linked layer of keratin normally impenetrable to bac-
teria. Additionally, skin displaysmicrobicidal activity via an
array of bioactive molecules, among which antimicrobialCellpeptides (AMPs) are of critical importance to host defense
(Ong et al., 2002; Niyonsaba and Ogawa, 2005). Bacteria
such as S. aureus, which colonize the skin and cause
disease, can resist host innate defenses by varied means,
including modification of the cellular envelope (Peschel,
2002; Nizet, 2006). In addition to AMPs, several free fatty
acids extracted from sebum on human skin possess
potent antimicrobial activity (Miller et al., 1988; Wille and
Kydonieus, 2003; Takigawa et al., 2005). In particular,
cis-6-hexadecanoic acid (C16:1D6, C-6-H) is the most
effective killing agent against S. aureus (Wille and Kydo-
nieus, 2003; Takigawa et al., 2005).
Surface proteins of S. aureus are required for virulence
and interact with many human extracellular matrix (ECM)
and serum proteins. Most previously characterized ECM
binding proteins are covalently bound to the cell wall pep-
tidoglycan (reviewed by Clarke and Foster, 2006). A cova-
lently attached surface protein, IsdA, is required for nasal
colonization and is expressed in vivo under conditions of
iron starvation (Clarke et al., 2004, 2006). Here we report
the importance of IsdA for resistance to human skin
defenses, in particular fatty acids. The skin fatty acids
have more than one mode of action and are effective in
control of infection by S. aureus.
RESULTS
IsdA Affects Cellular Physical Properties
Iron limitation is an environmental signal often indicative
of mammalian host-pathogen interaction (Schaible and
Kaufmann, 2004;Clarke et al., 2006). Under iron-starvation
conditions, IsdA is the predominant covalently attached
surface protein (Figure 1A). The effect that the presence
of IsdA has on cell surface hydrophobicity was measured
by microbial adhesion to hexadecane (MATH) test and
by water contact-angle analysis. Wild-type S. aureus
(SH1000 and Newman) grown without iron exhibited
decreased hydrophobicity compared to those grown with
iron (Figure 1B). This iron-deprivation-associated de-
crease in hydrophobicity was due to IsdA as SRC005
(isdA) and SRC105 (isdA) were not affected by ironHost & Microbe 1, 199–212, May 2007 ª2007 Elsevier Inc. 199
Cell Host & Microbe
S. aureus Resistance to Innate Defenses of SkinFigure 1. IsdA Affects Cellular Physical Properties
(A) Coomassie blue-stained 12% (wt/vol) SDS-PAGE gel of S. aureus SH1000 proteins covalently bound to the cell wall after growth in CL broth +
20 mM FeSO4 (lane A); CL broth (lane B). IsdA is a c. 38 kDa band with the N-terminal sequence ATEATNATNNQSTQV. The c. 28 kDa band present
in both lanes is lysostaphin which was used to digest cell wall material. The other 2 major protein bands present in lane B were identified as IsdB
(c. 82 kDa) and IsdC (c 22 kDa) with N-terminal sequences AAEETGGTNTEAQPK and ADSGTLNYE, respectively.
(B) Microbial adhesion to hydrocarbon (MATH) test on SH1000, SRC005 (isdA), Newman and SRC105 (isdA), with andwithout pIsdA and pMK4 grown
in CL broth and CL broth + 20mM FeSO4.
(C) Inhibition of hydrophobic interaction between hexadecane and SH1000 (black diamonds) or SRC005 (isdA) (black squares) grown in CL broth by
increasing DMSO concentrations.
(D) Role of IsdA in net cell surface charge determination (as represented by z potential) of strains SH1000, Newman and their respective isogenic isdA
mutants (SRC005, SRC105) grown in CL broth. Values are the mean of three independent experiments.
(E) Western blot analysis of proteins covalently bound to the cell wall of L. lactis containing pNZ8148 or pLIsdA (isdA+) probed with anti-IsdA sera (14).
(F) Effect of IsdA on physical properties of L. lactis. MATH test on L. lactis containing pNZ8148 or pLIsdA (isdA+). The L. lactis strains used lacked the
Nisin-inducible regulatory apparatus, thus gene expression from Pnis was constitutive.
All values are the mean of three independent experiments. Error bars indicate the standard error of the mean.availability (Figure 1B). The decrease in hydrophobicity
was isdA dependent as the complemented mutants
SRC005 (isdA) and SRC105 (isdA) carrying the wild-type
isdA+ gene on a multicopy plasmid behaved in the same
manner as wild-type (Figure 1B). In all cases, cells produc-
ing IsdA were significantly less hydrophobic than those
not producing the protein (p < 0.00001). Water contact
angles (q) of materials, in this case S. aureus cells grown
without FeSO4, increase with hydrophobicity (Absolom,
1988). q = 5 and 3 were found for SH1000 and Newman,200 Cell Host & Microbe 1, 199–212, May 2007 ª2007 Elsevierrespectively, while for strains SRC005 (isdA) and SRC105
(isdA), q = 11 and 9, respectively. Addition of dimethyl
sulfoxide (DMSO) to a bacterial suspension lowers the
surface tension of the suspending liquid and hence re-
duces interaction with hydrophobic substrates (Absolom,
1988). Increasing DMSO concentration led to a decrease
in adherence to hexadecane (Figure 1C), demonstrating
the hydrophobic nature of the interaction. Similar results
were obtained using S. aureus Newman and SRC105
(isdA) (Figure S1). The role of IsdA in net cell surfaceInc.
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interface between the bacterial surface and the aqueous
environment (z potential) (Wilson et al., 2001). The electro-
negative bacterial surface became more negatively
charged as a result of the presence of IsdA (Figure 1D).
In order to demonstrate that IsdA alone is capable of
altering cellular hydrophobicity, isdA was cloned into
Lactococcus lactis, a heterologous expression system
for Gram-positive bacterial surface proteins (Figure 1E).
The presence of IsdA in the cell wall of L. lactis led to de-
creased hydrophobicity of whole cells as measured by
MATH test (Figure 1F, p < 0.0001). Thus, IsdA has a signif-
icant role in determination of cellular physical properties.
Previously, it has been proposed that S. aureus protein
A (Spa) confers increased cellular hydrophobicity (Wad-
stro¨m, 1990). IsdB is another iron-regulated surface pro-
tein (Mazmanian et al., 2002; Figure 1A). Sortase A (SrtA)
is the enzyme responsible for the attachment to the cell
wall of all but one covalently bound S. aureus surface pro-
teins, including Spa, IsdB, and IsdA (Mazmanian et al.,
1999; Mazmanian et al., 2002). Under iron-replete condi-
tions, spa, isdB, and srtA mutations (Table S1) led to an
insignificant change in cellular hydrophobicity by the
MATH test (p > 0.05 in all cases; Figure S2). Under low-
iron conditions, the spa and isdB mutations resulted in
no difference compared to respective parents, as was
srtA compared to isdA (p > 0.1 in all cases, Figure S2).
Thus, under the conditions used, IsdA is the only cova-
lently attached S. aureus surface protein which signifi-
cantly affects cellular hydrophobicity.
The observations that in vitro binding of heme by
recombinant IsdA occurs (Mazmanian et al., 2003; Clarke
et al., 2004; Vermeiren et al., 2006; Grigg et al., 2007) led
us to investigate the role that this may play in affecting
cellular hydrophobicity. Binding of heme to S. aureus was
not affected by production of IsdA (Figure S3A) and did
not affect cellular hydrophobicity (Figure S3B).
IsdA Decreases Biofilm Formation
Increased cellular hydrophobicity is regarded as a factor
in the propensity of staphylococci to form biofilms (Go¨tz,
2002). Productionof IsdAbyS. aureusNewmansubstantially
reduced the culture’s ability to form a biofilm (Figure S4A),
as did heterologous expression of isdA in L. lactis
(Figure S4B). Therefore, in host niches where IsdA is im-
portant, biofilm formation may be reduced. The molecular
basis for lack of a role in SH1000 is unknown, but strain
variation in biofilm formation has been well established
(Johnson et al., 2005).
Decreased Cellular Hydrophobicity Affects
the Sensitivity of S. aureus to Elements
of Host Innate Defenses
We hypothesized that the change in hydrophobicity of
S. aureus, upon production of IsdA, would alter the organ-
ism’s sensitivity to bactericidal hydrophobic fatty acids
found on human skin sebum and, in particular, the potent
antistaphylococcal C-6-H (Wille and Kydonieus, 2003;
Takigawa et al., 2005). In killing assays, isdA mutantsCell Hwere more sensitive than their parents to human sebum
and C-6-H (Figures 2A–2D). Similarly, cells producing
IsdA (wild-type grown without iron) exhibited higher mini-
mum inhibitory concentrations (MICs) than those lacking
the protein (isdA mutants or wild-type grown with iron)
(Table 1). Complementation of the isdA mutation fully
restored the resistance phenotype (Figures 2A–2D). With
commonly available fatty acids (linoleic, lauric, capric,
and palmitoleic acid), IsdA gave increased resistance to
killing (Figure S5) andMICs (Table 1). Additionally, expres-
sion of isdA in L. lactis led to increased resistance to the
bactericidal effects of both sebum and C-6-H (Figures
2F and 2G). Therefore, IsdA confers protection to S. au-
reus against the bactericidal activity of sebum fatty acids
by decreasing cellular hydrophobicity, thus reducing the
potential for hydrophobic interactions. In order to confirm
that hydrophobic and/or ionic interactions are important
for C-6-H activity, DMSO was included in killing assays
to reduce the surface tension of the suspending liquid,
which led to increased survival (Figure S6). Increasing
concentrations of NaCl did not alter the survival rate
(data not shown). Thus hydrophobic, but not ionic, inter-
actions between C-6-H and S. aureus are important for
activity. Such surface protein mediated resistance to
skin fatty acids has not previously been described. Addi-
tion of heme to cells did not affect sensitivity to C-6-H
(data not shown).
Hydrophobic interactions are also required for AMPs
to interact with the bacterial cell envelope (Matsuzaki,
1999; Shai, 2002). The role of IsdA in AMP resistance
was tested via a series of killing assays using recombi-
nant human b-defensin 2 (hBD2), synthetic mouse cath-
elicidin (mCRAMP), and native human pulmonary surfac-
tant protein B (PSP-B). Expression of both hBD2 and
cathelicidin is induced in keratinocytes by S. aureus
(Ong et al., 2002). PSP-B is a hydrophobic peptide con-
stitutively secreted into the alveolar airspace and is bac-
tericidal for S. aureus (Ryan et al., 2006). In all instances,
iron-deprived S. aureus Newman was more resistant
than SRC105 (isdA) in a killing assay (Figure 2E). This
effect was not seen in the SH1000 strain background,
indeed no PSP-B killing was observed (data not shown).
Strain variation in sensitivity to host AMPs has been
reported previously (Komatsuzawa et al., 2006). All three
AMPs used are cationic and given that IsdA increases
the electronegative charge of S. aureus, it may result in
AMP sequestration thus preventing access to their cell
membrane target. This could be excluded, however, be-
cause addition of a molar excess of IsdA (5:1) did not
affect the killing activity of mCRAMP (data not shown).
Mutation of spa, isdB, or srtA had no effect on sensitivity
to C-6-H or mCRAMP under iron-replete conditions (data
not shown). Under iron-starved conditions, the sensitivity
of SRC055 (spa) and DU5873 (spa) to C-6-H and
mCRAMP was the same as their respective wild-types.
Strains SRC050 (srtA) and SRC150 (srtA) were just as
sensitive to C-6-H and mCRAMP as SRC005 (isdA) and
SRC105 (isdA) in MIC and killing assays, indicating that
under low-iron conditions, IsdA is the major covalentlyost & Microbe 1, 199–212, May 2007 ª2007 Elsevier Inc. 201
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Innate Defenses
(A–E) Black diamonds, wild-type (SH1000,
Newman); black squares, isdA (SRC005,
SRC105); black Xs, isdA (SRC005, SRC105)
(pMK4); black triangles, isdA (SRC005,
SRC105) (pIsdA), all grown in CL broth. (A)
Strains in SH1000 background treated with
40 mg/ml sebum. (B) Strains in SH1000 back-
ground treatedwith 10 mg/ml C-6-H. (C) Strains
in Newman background treated with 40 mg/ml
sebum. (D) Strains in Newman background
treated with 10 mg/ml C-6-H. (E) Strains in
Newman background treated with 5 mg/ml
hBD2, 10 mg/ml mCRAMP, 25 mg/ml PSP-B.
Note: in (A)–(E), black diamonds and black
triangles overlap, as do black squares and
black Xs.
(F and G) IsdA protects L. lactis against the
effects of human skin fatty acids. In both
graphs, L. lactis containing pLIsdA (black dia-
monds) or pNZ8148 (black squares), grown in
M17 broth, were used. (F) Cells treated with
5 mg/ml C-6-H. (G) Cells treated with 10 mg/ml
sebum.
In all panels, Student’s t test was applied to
T50 values (time taken to achieve 50% killing)
for wild-type and isdA mutant strains (A–E)
or L. lactis (F and G). *p < 0.01, **p < 0.001,
***p < 0.0001, ****p < 0.000001.
All values (A–G) are the mean of three inde-
pendent experiments. Error bars indicate the
standard error of the mean.attached surface protein responsible for resistance to
C-6-H and mCRAMP.
Previous studies have shown that the DltABCD and
MprF proteins of S. aureus act to decrease the net nega-
tive charge of the cell envelope by alanylating teichoic
acids and lysinylating membrane phosphatidylglycerol,
respectively (Peschel et al., 1999; Peschel et al., 2001).
Both surface charge modifications are associated with
increased in vitro resistance to cationic AMPs (Peschel
et al., 1999; Peschel et al., 2001; Weidenmaier et al.,
2005). Mutation of either dltA (in the SA113 background)
or mprF (in the SA113, SH1000, and Newman back-
grounds) had no effect on cellular hydrophobicity as202 Cell Host & Microbe 1, 199–212, May 2007 ª2007 Elsevierdetermined by MATH test or sensitivity to C-6-H or sebum
(data not shown). The dltA mutation could not be trans-
ferred to other backgrounds due to spontaneous specti-
nomycin resistance.
IsdA Is Required for Survival of S. aureus on Live
Human Skin
The above data, together with the finding that IsdA pro-
tects against bactericidal fatty acids, represent a potential
mechanism for protection of S. aureus against host innate
defenses on the skin. A DisdA mutant was used to study
survival of live bacteria on the skin of healthy human volun-
teers. Significantly higher numbers of wild-type thanInc.
Cell Host & Microbe
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both SH1000 and Newman strain backgrounds (p <
0.0002 and p < 0.00002, respectively; Figure 3). No other
S. aureus components required for survival on the human
host have been described previously.
IsdA Confers Resistance to Lantibiotics
Decreased cellular hydrophobicity due to unidentified
changes in the cell envelope of Listeria monocytogenes
has been found to be a cause of resistance to nisin (Davies
et al., 1996), a hydrophobic, positively charged (Chan-Ick
and Pyun, 2005) lantibiotic (lanthionine containing anti-
biotic). IsdA rendered S. aureus more resistant in killing
(Figure S7) and MIC assays (Table 1) to both nisin and
mersacidin (another hydrophobic lantibiotic, but with no
net charge; Chatterjee et al., 1992). Thus, iron limitation
in the host may make S. aureus more resistant to hydro-
phobic antibiotics than under standard laboratory growth
conditions, with implications for susceptibility testing.
Skin Fatty Acids Prevent Induction of Virulence
Factors and Antibiotic Resistance
in Gram-Positive Bacteria
In a range of Gram-positive bacteria, including S. aureus,
glycerol monolaurate (GML), a mild surfactant commonly
used as a food additive and in cosmetics, has been shown
to block expression of various virulence factors (in S. au-
reus, a-hemolysin, protein A, and toxic shock syndrome
toxin) and antibiotic resistance at sub-growth-inhibitory
concentrations (Schlievert et al., 1992; Holland et al.,
1994; Projan et al., 1994; Ruzin and Novick, 1998; Vetter
and Schlievert, 2005). Lauric acid, a fatty acid and product
of GML hydrolysis by S. aureus lipases, has equivalent in-
hibitory properties (Ruzin and Novick, 2000). The mecha-
nism of this inhibition is not known but is presumed to be
due to the surfactant nature of both substances. Neither
GML nor lauric acid inhibits secretion, and the effect is
most likely through the generic inhibition of signal trans-
duction (Projan et al., 1994; Ruzin and Novick, 1998).
However, the agr quorum sensing system is not inhibited
as the RNAIII effector molecule is still produced (Projan
et al., 1994). As we had noted a role for IsdA in the sensi-
tivity to human skin fatty acids, it was hypothesized that
sebum and C-6-H may inhibit virulence factor production.
The addition of C-6-H or sebum gave a dose-dependent
decrease in a-hemolysin (Hla) activity of S. aureus culture
supernatant (Figure 4A). Mutation of isdA led to a marked
decrease in the concentration of C-6-H or sebum needed
to inhibit Hla activity (Figure 4A). Experiments in the strain
Newman background gave comparable results (data not
shown). Comparison of Hla production in isdA mutants
containing either pIsdA or pMK4 grown in the presence
of 2.5 mg/ml sebum or 0.5 mg/ml C-6-H showed that com-
plementation restored resistance to both substances
(data not shown). Reporter gene (lacZ) fusion analysis
was used to determine at what level the inhibition oc-
curred. S. aureus strains (SH1000 and isdA backgrounds)
with lacZ fused to hla, spa, and RNAIII (hld) were grown in
iron-depleted medium, with and without sebum or C-6-H.CellTranscription of hla and spa was inhibited at sebum
and C-6-H concentrations of 20 mg/ml and 5 mg/ml (sub-
growth-inhibitory concentrations in iron-depleted TSB)
respectively (Figure S8). However, at (subinhibitory) con-
centrations of 5 mg/ml and 2.5 mg/ml (sebum and C-6-H,
respectively), transcription of hla and spa was only in-
hibited in the isdA strain (data not shown), which corre-
lates with the Hla assay data (Figure 4A). Moreover, agr
is not affected by sebum or C-6-H in the wild-type or
isdA strain (Figure S8 and data not shown). Thus, the ef-
fect is mediated at the transcriptional level, not inhibition
of agr, but likely occurs by inhibition of another signal
transduction pathway. Expression of isdA upon addition
of sebum (20 mg/ml) and C-6-H (5 mg/ml) was found, by
lacZ fusion assay, to be unaltered (data not shown). Al-
though GML can protect eukaryotic cells from Hla activity
(Peterson and Schlievert, 2006), this did not occur for se-
bum and C-6-H (data not shown). If inhibition of bacterial
virulence determinant production by human skin fatty
acids is an innate defense mechanism, then the phenom-
enon is unlikely to be S. aureus specific. Hemolysin pro-
duction by the Gram-positive pathogens Streptococcus
pyogenes and Streptococcus agalactiae (grown in BHI)
was inhibited in a dose dependent manner by sub-MICs
of sebum (Figure 4C) as has been shown for GML (Ruzin
and Novick, 1998). Interestingly, C-6-H only inhibited pro-
duction of hemolysin fromS. agalactiae. C-6-H and sebum
did not protect the rabbit erythrocytes directly from hemo-
lysin activity. Neither C-6-H nor sebum inhibited produc-
tion of pneumolysin by Streptococcus pneumoniae after
lysis of the bacteria (data not shown).
Resistance ofS. aureus to b-lactamantibiotics is amajor
problem, and methicillin-resistant S. aureus (MRSA) are
responsible for many deaths. Production of b-lactamase
is controlled by the bla regulatory apparatus, which is
often responsible for the regulation of mecA, the gene
encoding methicillin resistance, in many strains with
inducible resistance (Hackbarth and Chambers, 1993).
Sub-MICs of both sebum and C-6-H inhibited the induc-
tion of b-lactamase in S. aureus containing pI9787, and
IsdA repressed this inhibitory effect (Figure 4B). Vancomy-
cin has long been used as the antibiotic of last resort, but
the rise of resistant Enterococcus faecalis and the appear-
ance of vancomycin resistant S. aureus are of great
concern. Using E. faecalis JH2-2, it was found that at
sub-MIC levels of C-6-H and sebum, vancomycin resis-
tance was inhibited (Figure 4D). This likely occurs by inhi-
bition of resistance induction as for GML (Ruzin and
Novick, 1998) but could reflect a synergistic inhibition of
growth. Thus, human skin defenses can prevent antibiotic
resistance in important pathogens.
The C Domain of IsdA Is Responsible for Resistance
Properties and Increased Survival on Human Skin
The well-documented ligand binding activity of IsdA has
been mapped to its NEAT domain, near the IsdA N termi-
nus end (Figure S9) (Clarke et al., 2004; Vermeiren et al.,
2006), whereas the function of the C-terminal domain is
unknown. In-frame deletions of the NEAT (amino acidHost & Microbe 1, 199–212, May 2007 ª2007 Elsevier Inc. 203
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SH1000 (S); Newman (N) Medium ±FeSO4
MIC
(mg/ml)
Sebum SH1000 wild-type (S) CL + 10
Sebum SH1000 wild-type (S) CL  30
Sebum SRC005 isdA (S) CL + 10
Sebum SRC005 isdA (S) CL  10
Sebum Newman wild-type (N) CL + 10
Sebum Newman wild-type (N) CL  30
Sebum SRC105 isdA (N) CL + 10
Sebum SRC105 isdA (N) CL  10
Sebum SRC008 isdADNEAT domain (S) CL  30
Sebum SRC108 isdADNEAT domain (N) CL  30
Sebum SRC009 isdADC domain (S) CL  10
Sebum SRC109 isdADC domain (N) CL  10
C-6-H SH1000 wild-type (S) CL + 2.5
C-6-H SH1000 wild-type (S) CL  10
C-6-H SRC005 isdA (S) CL + 2.5
C-6-H SRC005 isdA (S) CL  2.5
C-6-H Newman wild-type (N) CL + 2.5
C-6-H Newman wild-type (N) CL  10
C-6-H SRC105 isdA (N) CL + 2.5
C-6-H SRC105 isdA (N) CL  2.5
C-6-H SRC008 isdADNEAT domain (S) CL  10
C-6-H SRC108 isdADNEAT domain (N) CL  10
C-6-H SRC009 isdADC domain (S) CL  2.5
C-6-H SRC109 isdADC domain (N) CL  2.5
Sebum SH1000 wild-type (S) CT-TSB  80
Sebum SRC005 isdA (S) CT-TSB  50
Sebum Newman wild-type (N) CT-TSB  100
Sebum SRC105 isdA (N) CT-TSB  50
C-6-H SH1000 wild-type (S) CT-TSB  50
C-6-H SRC005 isdA (S) CT-TSB  25
C-6-H Newman wild-type (N) CT-TSB  50
C-6-H SRC105 isdA (N) CT-TSB  25
Capric acid SH1000 wild-type (S) CL  10
Capric acid SRC005 isdA (S) CL  2.5
Capric acid Newman Wild-type (N) CL  40
Capric acid SRC105 isdA (N) CL  5
Lauric acid SH1000 wild-type (S) CL  20
Lauric acid SRC005 isdA (S) CL  1.25
Lauric acid Newman wild-type (N) CL  20
Lauric acid SRC105 isdA (N) CL  5
Linoleic acid SH1000 wild-type (S) CL  20204 Cell Host & Microbe 1, 199–212, May 2007 ª2007 Elsevier Inc.
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SH1000 (S); Newman (N) Medium ±FeSO4
MIC
(mg/ml)
Linoleic acid SRC005 isdA (S) CL  2.5
Linoleic acid Newman wild-type(N) CL  20
Linoleic acid SRC105 isdA(N) CL  2.5
Palmitoleic acid SH1000 wild-type (S) CL  20
Palmitoleic acid SRC005 isdA (S) CL  2.5
Palmitoleic acid Newman wild-type (N) CL  20
Palmitoleic acid SRC105 isdA (N) CL  2.5
Nisin Newman wild-type (N) CL  5
Nisin SRC105 isdA (N) CL  2.5
Nisin SRC108 isdADNEAT domain(N) CL  5
Nisin SRC109 isdADC domain(N) CL  2.5
Mersacidin Newman wild-type (N) CL  40
Mersacidin SRC105 isdA (N) CL  20
Mersacidin SRC108 isdADNEAT domain (N) CL  40
Mersacidin SRC109 isdADC domain (N) CL  20
Serial dilutions of antimicrobials were used and MICs taken as the lowest concentration which inhibited growth. S. aureus strains
were grown in CL or CT-TSBbroth, with or without 20 mMFeSO4 for 16 hr at 37
Cwith shaking. All assayswere repeated three times
with the same result.residues I69 to E177 deleted) and C (amino acid residues
K178 to K311 deleted) domains (Figure S9) were created
in S. aureus (Figure S10A), and corresponding proteins
produced in L. lactis. A western blot of IsdB confirmed
loading of consistent amounts of cell wall material to
each lane (Figure S10B).
The roles of IsdA domains in determining cell surface
hydrophobicity were measured by the MATH test. S. au-
reus SRC008 (isdADNEAT) and SRC108 (isdADNEAT) (in
SH1000 and Newman, respectively) grown without iron
exhibited decreased hydrophobicity compared to those
from iron-replete media, as do their parents (Figure 5A).
S. aureus SRC009 (isdADC) and SRC109 (isdADC) (in
SH1000 and Newman, respectively) did not display any
change in hydrophobicity when iron depleted, similar to
SRC005 (isdA) and SRC105 (isdA) (Figure 5A), but did pos-
sess fibrinogen binding activity, demonstrating its expo-
sure to the extracellularmilieu (Figure S11). Neithermutant
form of IsdA enhanced binding of heme to S. aureus (Fig-
ures S3A and S3B). The production of full-length IsdA from
the complementation plasmid (pIsdA) restored the dy-
namic hydrophobicity properties of the cells (Figure 5A).
In all cases, cells expressing IsdA or IsdADNEATwere sig-
nificantly less hydrophobic that those expressing IsdADC
or the mutant (p < 0.00001). There was no significant
difference between IsdA and IsdADNEAT (p > 0.1) or
IsdADC and no IsdA (p > 0.1). In L. lactis, the presence
of IsdADNEAT (p < 0.0001) or full-length IsdA, but not
IsdADC (p > 0.05), led to decreased cellular hydrophobicity
as measured by the MATH test (Figure S12A). Thus, theCell Hchange in cellular hydrophobicity observed upon produc-
tionof IsdA isdue to theCdomainandnot theNEATdomain.
The C domain of IsdA is also required for resistance to
host innate defenses.S. aureus producing IsdADNEAT ex-
hibitedwild-type resistance, asmeasured byMIC (Table 1)
and killing assays (Figures 5B and 5C), whereas cells
producing IsdADC possessed the same phenotype as
isdAmutants (Table 1; Figures 5B and 5C). Complementa-
tion of the isdADC mutation with isdA fully restored
Figure 3. IsdA Is Required for Survival on Human Skin
Human skin survival of strains SH1000, SRC007 (isdA), Newman, and
SRC107 (isdA) 4 hr after application as measured by cfu. Dashed lines
represent mean values. yp < 0.0002, zp < 0.00002 by paired two sam-
ple Student’s t test.ost & Microbe 1, 199–212, May 2007 ª2007 Elsevier Inc. 205
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S. aureus Resistance to Innate Defenses of SkinFigure 4. Human Sebum and C-6-H Inhibit Bacterial Toxin Production and Induction of Antibiotic Resistance
Black diamonds (SH1000) and black squares (SRC005) (isdA) are in (A) and (B). The concentration of sebum or C-6-H used had no effect on growth
rate or yield.
(A) Effect of sebum or C-6-H on Hla activity in S. aureus culture supernatant.
(B) Effect of sebum or C-6-H on S. aureus b-lactamase activity.
(C) Effect of sebum (black diamonds, black triangles) or C-6-H (black squares) on culture supernatant hemolysin activity of S. agalactiae 6313 (black
diamonds, black squares) and S. pyogenes JRS4 (black diamonds).
(D) Effect of sebum (25 mg/ml) and C-6-H (12.5 mg/ml) on vancomycin resistance in E. faecalis JH2-2. C-6-H and sebum concentrations used in
experiments with S. agalactiae, S. pyogenes, and E. faecalis were%0.5 the determined MIC and did not affect growth rate or yield.
All values are the mean of three independent experiments. Error bars indicate the standard error of the mean.resistance (Figure 5B, C). Experiments in L. lactis showed
that production of IsdADNEAT, but not IsdADC, conferred
increased resistance to killing by sebum and C-6-H (Fig-
ures S12B and S12C).
S. aureus SRC108 (Newman isdADNEAT), but not
SRC109 (Newman isdADC), showed parental resis-
tance levels in killing assays to mCRAMP and PSP-B
(Figure 5D). Similarly, S. aureus SRC108 (Newman isdAD
NEAT) but not SRC109 (Newman isdADC) displays the
parental iron-associated change in MICs (Table 1) and
resistance to killing by nisin and mersacidin (Newman)
(data not shown).
The role of the IsdA C domain in survival of bacteria on
human skin was tested.When applied to the skin of human
volunteers, there was no difference between the survival
rates of S. aureus strains SH1000 and SRC008 (isdAD206 Cell Host & Microbe 1, 199–212, May 2007 ª2007 ElsevierNEAT) (Figure 5E). However, significantly higher numbers
ofSH1000 thanSRC009 (isdADC) bacteriawere recovered
(Figure5E). Thus theCdomainof IsdA is responsible for the
ability of IsdA to promote survival of S. aureus on human
skin, likely via resistance to human innate defenses.
The role of the C domain of IsdA in resistance to sebum
or C-6-H, inhibition of a-hemolysin, and b-lactamase
expression was tested. Loss of the IsdA C domain in
S. aureus SRC009 (isdADC) but not the NEAT domain in
SRC008 (isdADNEAT) led to a marked decrease in the
concentration of C-6-H or sebum required to inhibit Hla
(Figure 5F) and b-lactamase (Figure 5G) induction com-
pared to SH1000 with similar results in Newman (data
not shown). Comparison of Hla production in isdADC
mutants containing either pIsdA or pMK4 grown in the
presence of 2.5 mg/ml sebum or 0.5 mg/ml C-6-H showedInc.
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stances (data not shown).
Skin Fatty Acids Can Cure S. aureus Disease
Thus, human sebum, and in particular C-6-H, can disable
a number of Gram-positive pathogens at several levels.
There has been much speculation regarding the use of
innate host defense components in treatment of infections.
Indeed, the structure-function relationships of host anti-
microbial peptides have been used to design de novo
inhibitors (Shai, 2002). To test the therapeutic potential
of C-6-H, it was used to treat mice in a number of experi-
ments (see Supplemental Experimental Procedures). In a
mouse model of systemic S. aureus infection, injection of
C-6-H led to significantly reduced bacterial load with two
different inocula (Figure 6A; Figure S13) and decreased
production of proinflammatory cytokine IL-6 (Figure 6B).
At an increased inoculum (7.5 3 107 cfu), treatment with
C-6-H completely prevented death (n = 10), compared to
4 deaths out of 10 for the control. Also, in an atopic derma-
titis model with superimposed S. aureus infection, topical
application of C-6-H led to a highly significant reduction
of S. aureus cfu present (Figure 6C).
DISCUSSION
The interaction between S. aureus and its human host is
complex and multifactorial as it can colonize several
host niches, both as an opportunist pathogen of great
medical significance and a commensal in the nose and
on skin. Iron deprivation is a common host environmental
stimulus, and, in response to this, S. aureusmakes a pre-
dominant cell-wall-bound protein IsdA. Previously, IsdA
has been shown to bind to many different human ligands,
to be an adhesin, and to be required for nasal coloniza-
tion (Taylor and Heinrichs, 2002; Clarke et al., 2004,
2006). The prevalence of IsdA led us to hypothesize that,
in fact, this protein may affect the cellular physical proper-
ties. Surprisingly, the presence of IsdA rendered S. aureus
more hydrophilic and negatively charged. No other Gram-
positive cell-wall-bound protein has previously been
shown with such a role, and our data suggest that in
S. aureus, there are no other such proteins which affect
cellular hydrophobicity. In fact, many adhesins make bac-
teria more hydrophobic (Wadstro¨m, 1990). This apparent
paradox was resolved when IsdA was found to have an
additional function in resistance to host innate defense
mechanisms such as fatty acids and antimicrobial pep-
tides, which require hydrophobic interaction for their
activity. Our data show that the C domain of IsdA is
responsible for this action and that the ligand binding
NEAT domain does not influence the physical properties
of the cell. Recent studies have examined the structure
of IsdA and shown it to be an extended asymmetric mono-
mer in solution, which is proposed to allow themolecule to
extend into the extracellular environment (Vermeiren et al.,
2006). The structure of the NEAT domain has been solved
and shown to consist of b sheet formation and a hydropho-
bic heme binding pocket (Grigg et al., 2007). However, theCell HNEAT domain has no role in determining overall cellular
hydrophobicity. Therefore, we propose that the C-domain
of IsdA protrudes through the cell wall, altering cellular
charge and hydrophobicity.
Innate defense mechanisms form part of the primary
interface between the host and potential pathogens.
This interaction is dynamic and there are a number of
bacterial mechanisms involved in overcoming the host de-
fenses such as charge alterations (reviewed by Peschel,
2002; Nizet, 2006), efflux pumps (Kupferwasser et al.,
1999; Bayer et al., 2000), and modification enzymes
(Chamberlain and Brueggemann, 1997; Sieprawska-
Lupa et al., 2004; Jin et al., 2004; Lai et al., 2007).S. aureus
has the additional capacity, in response to the host envi-
ronment, to become less hydrophobic and so reduce its
susceptibility to key host defenses. This is highlighted by
the fact that IsdA is required for survival on live human
skin in a volunteer model. Although iron is lost through hu-
man skin in sweat (Cohn and Emmett, 1978) and primarily
by desquamation of epithelial cells (Croft, 1970; Molin and
Wester, 1976), it is not biologically available as it is
sequestered by storage proteins such as transferrin and
ferritin (Fisher, 1965; Nakayashiki, 1990; Milstone et al.,
2006). Skin fatty acids are potent bactericidal agents
and help to prevent colonization by potential pathogens.
They are an important facet of our innate defenses, and,
in fact, a toll-like receptor mediated pathway in mice leads
to increased fatty acid production and protection against
S. aureus skin infections (Georgel et al., 2005). S. aureus
is important in atopic dermatitis, and fatty acids are able
to reduce the severity of infection (Takigawa et al., 2005;
Gilani et al., 2005). Fatty acids are also able to killS. aureus
within abscesses (Dye and Kapral, 1981). In particular,
C-6-H has been purified from human skin as the major
bactericidal fatty acid for S. aureus (Wille and Kydonieus,
2003; Takigawa et al., 2005). Patients with atopic derma-
titis show reduced C-6-H levels and increased coloniza-
tion with S. aureus. Topical treatment with C-6-H results
in a decrease in S. aureus levels (Takigawa et al., 2005).
Our observation that C-6-H can be used to treat experi-
mental atopic dermatitis, and, in fact, systemic infection
byS. aureus, opensup thepossibility of a novel rangeof an-
tibiotics exploiting natural host defenses. New treatments
for S. aureus are acutely required due to the alarming
spreadof antibiotic resistant strains (Marcheseet al., 2000).
How C-6-H and other fatty acids kill S. aureus is
unknown, but is likely to include more than one mecha-
nism. Fatty acids have been shown to inhibit many bacte-
rial uptake and biosynthetic pathways, possibly due to the
uncoupling of ATP synthesis (Galbraith and Miller, 1973;
Greenway and Dyke, 1979). Linoleic acid can be taken
up and incorporated into lipid containing compounds
(Greenway and Dyke, 1979; Greenway and Dyke, 1980).
If lipid hydroperoxides are produced these are highly toxic
to bacterial cells (Memon et al., 2000; Klomsiri et al., 2005).
Of course it is also likely that the surfactant properties of
C-6-H result in disruption of the membrane and lysis.
Our work has also highlighted a novel mechanism of
action for skin fatty acids, which is likely to contributeost & Microbe 1, 199–212, May 2007 ª2007 Elsevier Inc. 207
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(A) Microbial adhesion to hydrocarbon (MATH) test on SH1000, SRC008 (SH1000 isdADNEAT), SRC009 (SH1000 isdADC), Newman, SRC108
(Newman isdADNEAT), and SRC109 (Newman isdADC), with and without pIsdA and pMK4 grown in CL broth and CL broth + 20 mM FeSO4.
(B–D) Red triangles, wild-type; blue squares, isdA; pink Xs, isdADNEAT; orange circles, isdADC; blue diamonds, isdADC (pIsdA); green squares,
isdADC (pMK4). In (B) and (C), Student’s t test was applied to T50 values (time taken to achieve 50% killing) for wild-type and isdA mutant strains.
*p < 0.01, **p < 0.001, ***p < 0.0001, ****p < 0.000001. (B) Strains in SH1000 background treated with 10 mg/ml C-6-H or 40 mg/ml sebum. (C) Strains208 Cell Host & Microbe 1, 199–212, May 2007 ª2007 Elsevier Inc.
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S. aureus Infection in Mouse Models
(A) Impact onS.aureuscfu in kidneysof infected
miceby injectionofC-6-H (n=10) or PBS (n=9),
mice were inoculated with 2.53 107 cfu.
(B) IL-6 production in S. aureus infected mice
treated with C-6-H (n = 9) or PBS (n = 9).
(C) Effect of C-6-H (n = 20) or PBS (n = 19) on
S. aureus cfu in a chronic dermatitis with
superimposed infection model. *p < 0.0002,
**p < 0.0001, ***p < 0.03 by Student’s t test.
Dashed lines represent mean values.to their ability to disarm several important pathogens. Sur-
prisingly, treatment of S. aureus with sub-MIC of C-6-H or
sebum suppressed the production of key virulence factors
and b-lactamase in a dose dependent manner at the tran-
scriptional level. Previously, the food additive GML has
also been shown to have this effect (Schlievert et al.,
1992; Projan et al., 1994; Holland et al., 1994) and we
would hypothesize that their proposed mechanism of
action is similar (partitioning into the cell membrane and
inhibition of signal transduction processes). However, the
key quorum-sensing regulator, Agr, is not affected by
GML (Projan et al., 1994) or C-6-H, and, thus, the mecha-
nism is likely agr independent. Virulence determinant reg-
ulation in S. aureus is complex, and more than one signal
transduction pathway may be affected. IsdA renders the
bacteria much more resistant to the inhibitory effects of
the fatty acids and thus will allow the organism to colonize
more effectively in response to the host environment.
The virulence determinant and antibiotic resistance in-
hibitory capabilities of skin fatty acids are not unique to
S. aureus, and, in fact, a number of important Gram-
positive pathogens are affected as has been found for
GML (Schlievert et al., 1992). Interestingly, however,
sebum, but not C-6-H, inhibited induction of hemolysin
synthesis in S. pyogenes suggesting that specific recep-
tors for fatty acids may be present in Gram-positive bac-
teria. Human skin therefore has the ability to specifically
disrupt important virulence-associated mechanisms of
bacterial pathogens. This is further evidence of the com-
plex and unfolding interplay between humans and oppor-
tunist pathogens.
IsdA is amultifunctional surface protein with a key role in
host-pathogen interaction. Its study has revealed several
novel aspects of the constant conflict between S. aureus
and its human host defense mechanisms. The human
skin is our largest organ and, via the presence of fatty
acids and other antimicrobials, is able to resist the con-
stant threat from potentially invading microorganisms.CellExploitation of natural fatty acids may lead to new anti-
microbial compounds to help combat the tide of drug
resistant pathogens.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Plasmids
Strains and plasmids are listed in Table S1. E. coli was grown on LB
medium, with ampicillin (100 mg/ml) or kanamycin (50 mg/ml) where ap-
propriate. S. aureus was grown in brain-heart infusion (BHI) medium
(Oxoid), chemically defined CL medium (Horsburgh et al., 2001), or
iron-limited tryptic soy broth (TSB) (Oxoid) Chelex treatedwith addition
of 10 mM 2,20-dipyridyl (Baldassarri et al., 2001). Antibiotics used were
erythromycin 5 mg/ml, lincomycin 25 mg/ml, chloramphenicol 5 mg/ml,
or tetracycline 4 mg/ml. L. lactis was grown in M17 medium (Oxoid) at
30C with 0.5% (w/v) glucose with chloramphenicol (10 mg/ml) where
appropriate. All E. coli and S. aureus cultures were grown at 37C
unless otherwise stated. S. aureus 411 phage transductions were as
described previously (Novick, 1967).
Microbial Adhesion to Hydrocarbons Test
(Rosenberg et al., 1980). Washed bacteria were suspended in dH2O
(OD600 of 1.0). Three milliliters of bacterial suspension (grown without
antibiotic selection) was placed in an acid-washed test tube and 100 ml
of hexadecane added. The mixture was vortexed vigorously for 30 s
and allowed to settle for 30 min. A proportion of the aqueous phase
was removedwithaglasspipette, theOD600wasmeasured, and theper-
cent recovery was determined.
Water Contact-Angle Measurements
Microscope slides (19.76 cm2) were coated with 2 ml bacterial sus-
pension (c. 23108 cfu/ml) and allowed to air dry. 200 nl of dH2O was
dropped onto the dried film of bacteria using a microsyringe, and
the contact angle between dH2O and bacteria was measured as
described previously (Absolom, 1988).
Bacterial Killing Assays
Bacteria were grown to an OD600 of c. 0.6 in CL broth and were
harvested by centrifugation and washed twice in sterile dH2O. Cell
suspensions (c. 13108 cfu/ml in dH2O) were incubated at 37
C with
fatty acids or peptides (see figure legends), and cfu was determined
over time. Compounds used were: hBD2 (Bachem), mCRAMP (Emory
University Microchemical Facility), native PSP-B (Ryan et al., 2006),in Newmanbackground treatedwith 10mg/mlC-6-Hor 40mg/ml sebum. (D) Strains inNewman background treatedwith 10 mg/mlmCRAMPor 25 mg/ml
PSP-B. Note: in graphs (B)–(D), red diamonds, pink Xs, and blue diamonds all overlap as do blue squares, orange circles, and green squares.
(E) Human skin survival of strains SH1000, SRC008 (isdADNEAT), and SRC009 (isdADC) 4 hr after application, as measured by cfu. Dashed lines
represent mean values. yp > 0.3, zp < 0.000001 by paired two sample Student’s t tests.
(F and G) red diamonds, SH1000; blue squares, SRC005 (isdA); pink Xs, SRC008 (isdADNEAT); orange circles, SRC009 (isdADC). (F) Effect of sebum
or C-6-H on Hla activity in S. aureus culture supernatant. (G) Effect of sebum or C-6-H on S. aureus b-lactamase activity. Note: in graphs (F) and (G),
red diamonds and pink Xs overlap, as do blue squares and orange circles.
All values (A–G) are the mean of three independent experiments. Error bars indicate the standard error of the mean.Host & Microbe 1, 199–212, May 2007 ª2007 Elsevier Inc. 209
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S. aureus Resistance to Innate Defenses of SkinC-6-H (Matreya), and fatty acids (capric, lauric, linoleic, and palmitoleic
acid; Sigma).
Human Skin Survival Model
Based on a previously described method (Lacey and Lord, 1981),
plastic rings (2 cm diameter) were taped to the inner forearms of
healthy human volunteers (ages 23–44 years) who had refrained from
applying antibacterial personal hygiene products for 24 hr. Bacteria
(OD600 of c. 0.6 in CL broth) were harvested by centrifugation and
washed twice in sterile dH2O. Ten microliters of bacterial suspension
(c. 13108 cfu/ml) was spread onto the defined area and covered
with microporous tape. After 4 hr, the bacteria were washed off the
skin by application of 1 ml sterile PBS and agitation using a plastic
rod and enumerated by serial dilution and cfu determined. No bacteria
were recovered from controls which had sterile PBS applied. Only
S. aureus, which was confirmed by PCR, was recovered from volun-
teer skin. The model was subject to full ethical approval by the Univer-
sity of Sheffield (Ref: NCT04/37).
Supplemental Data
The Supplemental Data include 13 supplemental figures, two supple-
mental tables, and Supplemental Experimental Procedures and can be
found with this article online at http://www.cellhostandmicrobe.com/
cgi/content/full/1/3/199/DC1/.
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